We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current RLAY market cap is 884.15M. The company's latest EPS is USD -2.6069 and P/E is -2.58.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | -2.92M | 10.8M | 1.23M | 2.27M | 26.4M |
Operating Income | -85.89M | -72.85M | -101.18M | -106.05M | -73.58M |
Net Income | -84.17M | -67.5M | -94.24M | -98.51M | -65.73M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 82.65M | 3.03M | 13.06M | 31.97M |
Operating Income | -84.05M | -55.8M | -364.7M | -299.28M | -373M |
Net Income | -75.31M | -230.2M | -363.87M | -290.51M | -341.97M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 1.17B | 1.1B | 1.04B | 962.02M | 906.96M |
Total Liabilities | 168.95M | 149.55M | 154.15M | 151.9M | 128.59M |
Total Equity | 999.77M | 950.22M | 883.41M | 810.12M | 778.37M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 393.07M | 799.83M | 1.01B | 1.1B | 843.98M |
Total Liabilities | 35.73M | 36.54M | 110.64M | 149.55M | 91.98M |
Total Equity | -180.44M | 763.29M | 897.81M | 950.22M | 752M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -172.41M | -229.49M | -67.13M | -135.73M | -211.13M |
Investing | -41.81M | -188.75M | 75.31M | 126.59M | 197.96M |
Financing | 288.74M | 289.91M | 1.3M | 3.38M | 12.84M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -66.13M | -102.49M | -74.41M | -229.49M | -300.32M |
Investing | -319.02M | 81.67M | -479.51M | -188.75M | 257.63M |
Financing | 5.61M | 426.51M | 388.09M | 289.91M | 34.75M |
Market Cap | 884.15M |
Price to Earnings Ratio | -2.58 |
Price to Sales Ratio | 27.57 |
Price to Cash Ratio | 6.13 |
Price to Book Ratio | 1.17 |
Dividend Yield | - |
Shares Outstanding | 131.18M |
Average Volume (1 week) | 985.88k |
Average Volume (1 Month) | 1.2M |
52 Week Change | -40.04% |
52 Week High | 13.32 |
52 Week Low | 5.70 |
Spread (Intraday) | 0.22 (3.2%) |
Company Name | Relay Therapeutics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.relaytx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions